Transforming your business with Microsoft Devices

Jo BakerEUC Device and Tools Lead Nov 2016

Jo Baker End User Computing, Device and Tools Lead

AstraZeneca

AstraZeneca is a global, science lead biopharmaceutical organisation, with over 50,000 staff.As the Device and Tools lead working in End User Computing, Jo sources and evaluates new technology that meets the requirements of the business.

Recommending devices to maximise productivity and minimise spend is a key part of his responsibilities, working with the wider workplace teams to deliver the latest solutions to the business to help them meet and exceed their goals.

The changing landscape of recording lab work

From sticky notes and paper to

electronic forms and direct note taking

From printed tables and scribbled numbers to

direct data recording in Excel and custom apps

The best fit for the requirements

Wipe clean screen

Detachable keyboard

Multiple input methods

Kickstand

Windows is still a better OS for legacy apps

Surface Pro 3: Electronic Lab Notebooks

650 devices deployed in 2015

Increase efficiency

Reduce error

Improve safety

Continued use after 12 months

Shift from companion to main device with Win10

Surface Pro 4: One device, multiple situations

It’s a Tablet

It’s also a Laptop

It’s a full time device and not a companion

It’s the right tool for the right job

Flexibility is Surface Pro4’s party trick

Touch and pen

Mouse and keyboard

Create, Consume, Collaborate, Showcase

Windows 10 – Because it’s not just about the device

Get your corporate build ready early

Applications working is one thing, how they work with the OS is the real goal

Work with your application vendors to ensure they’re Win10 ready, if not…

consider a change

Battery life / performance can be impacted if you get it wrong

Leverage your MSFT relationships

Confidentiality Notice

This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove

it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the

contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 1 Francis Crick Avenue, Cambridge Biomedical Campus,

Cambridge, CB2 0AA, UK, T: +44(0)203 749 5000, www.astrazeneca.com

9